NPI: 1750392304 · LOVELAND, CO 80538 · Emergency Care Clinic/Center · NPI assigned 08/10/2006
Authorized official THOMPSON, DAVID controls 20+ related entities in our dataset. Read more
| Authorized Official | THOMPSON, DAVID (CFO) |
| NPI Enumeration Date | 08/10/2006 |
Other providers sharing the same authorized official: THOMPSON, DAVID
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 31,726 | $1.46M |
| 2019 | 25,043 | $938K |
| 2020 | 7,137 | $272K |
| 2021 | 22,637 | $1.05M |
| 2022 | 15,337 | $545K |
| 2023 | 11,810 | $352K |
| 2024 | 6,445 | $176K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21,383 | 18,615 | $1.64M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 12,343 | 10,365 | $1.11M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7,469 | 6,726 | $420K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,886 | 1,603 | $398K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,979 | 2,663 | $281K |
| 0002A | 2,646 | 2,462 | $224K | |
| 0001A | 1,975 | 1,841 | $169K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 5,554 | 5,049 | $130K |
| 80053 | Comprehensive metabolic panel | 4,952 | 4,257 | $92K |
| 0004A | 1,325 | 1,296 | $87K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,260 | 2,031 | $29K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 364 | 354 | $29K |
| 86140 | 819 | 771 | $24K | |
| 0064A | 280 | 277 | $19K | |
| 0003A | 184 | 182 | $16K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 20,945 | 18,622 | $15K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 31 | 26 | $10K |
| 0012A | 102 | 98 | $9K | |
| 36415 | Collection of venous blood by venipuncture | 3,174 | 2,893 | $9K |
| 86769 | 213 | 199 | $9K | |
| 0054A | 278 | 272 | $9K | |
| 0071A | 75 | 70 | $7K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 91 | 88 | $6K |
| 0072A | 66 | 60 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 66 | 63 | $5K |
| 85652 | 784 | 743 | $5K | |
| 0352U | 226 | 215 | $5K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 53 | 47 | $4K |
| 80061 | Lipid panel | 118 | 115 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 146 | 81 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6,533 | 5,757 | $3K |
| 0124A | 85 | 85 | $3K | |
| 85027 | 542 | 381 | $3K | |
| 82565 | 103 | 93 | $3K | |
| 86780 | 216 | 207 | $2K | |
| 80076 | 114 | 111 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 183 | 174 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 34 | 31 | $2K |
| 84484 | 124 | 101 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 82 | 78 | $1K |
| 87480 | 199 | 190 | $1K | |
| J3490 | Unclassified drugs | 8,012 | 4,436 | $1K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 95 | 41 | $1K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 439 | 396 | $1K |
| 87510 | 199 | 190 | $1K | |
| 73630 | 26 | 13 | $803.88 | |
| 84443 | Thyroid stimulating hormone (TSH) | 122 | 108 | $742.61 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 82 | 78 | $728.70 |
| 87660 | 199 | 190 | $633.86 | |
| 97535 | Self-care/home management training, each 15 minutes | 24 | 12 | $588.84 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 12 | 12 | $546.84 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 182 | 175 | $410.54 |
| 82040 | 76 | 69 | $277.29 | |
| 71045 | Radiologic examination, chest; single view | 546 | 461 | $258.55 |
| 84075 | 74 | 68 | $144.46 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 923 | 817 | $140.98 |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,140 | 955 | $125.07 |
| 81025 | 420 | 355 | $101.05 | |
| 84439 | 12 | 12 | $86.86 | |
| 84450 | 75 | 69 | $74.13 | |
| 84460 | 75 | 69 | $71.91 | |
| 81003 | 759 | 669 | $57.57 | |
| 82950 | 12 | 12 | $47.49 | |
| J2704 | Injection, propofol, 10 mg | 2,149 | 1,425 | $11.65 |
| 84703 | 13 | 12 | $10.26 | |
| 83690 | 342 | 282 | $5.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 112 | 90 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 448 | 347 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 645 | 584 | $0.00 |
| 71046 | Radiologic examination, chest; 2 views | 60 | 49 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 133 | 118 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 101 | 50 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 26 | 25 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 13 | 13 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 135 | 69 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 15 | 14 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 47 | 36 | $0.00 |
| 80306 | 13 | 12 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 114 | 55 | $0.00 |
| 81001 | 490 | 415 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 647 | 550 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 65 | 39 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 12 | 12 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 14 | 14 | $0.00 |
| 82077 | 12 | 12 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 23 | 13 | $0.00 |